ALK-independent drug resistance usually necessitates treatment with a combination of drugs, and many studies have shown that although ALK inhibition decreases tumor cell survival and proliferation, many cellular changes caused by ALK overexpression are not reversed such as IL-10RA and IGF-1R dysregulation (59, 62–64, 68). The gene discussed is ALK; the disease is neoplasm.